C07D 209 - Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom

Patents for C07D 209 - Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom (45,780)
11/2001
11/21/2001	EP1156050A2 Substituted tricyclics useful in sPLA2 induced diseases
11/21/2001	EP1156049A1 Substituted heterocyclic compounds, their process of preparation and pharmaceutical compositions containing them
11/21/2001	EP1156039A1 Pyridazin-3-one derivatives and medicines containing the same
11/21/2001	EP1156037A1 Chondrongenesis promotors and indolin-2-one derivatives
11/21/2001	EP1154774A1 Quinazoline derivatives as angiogenesis inhibitors
11/21/2001	EP0914319B1 Diarylalkyl cyclic diamine derivatives as chemokine receptor antagonists
11/21/2001	EP0807102B1 Alkoximino acetic acid amides
11/21/2001	EP0659179B1 Benzo-fused lactams promote release of growth hormone
11/21/2001	CN1323295A AZA-bicycles which modulate the inhibition of cell adhesion
11/21/2001	CN1323289A Aminoalcohol derivatives and their use as beta 3 adrenergic agonists
11/21/2001	CN1323200A New oral formulation for 5-HT4 agonists or antagonists
11/21/2001	CN1322526A Compound for treating female sexual dysfunction
11/21/2001	CN1075061C Heterocyclylbenzonitriles
11/21/2001	CN1075060C Alkoxy-alkyl-substituted 1-H-3-aryl-pyrrolidine-2.4-diones uses as herbicides and pesticides
11/21/2001	CN1074902C Fungicidal active compound composition
11/20/2001	US6320058 Subjecting solution of phthalonitrile in tetrahydrofuran, mixture of tetrahydrofuran and water, or dimethoxyethane to hydrogen pressure of 100 to 180 bars, at temperature of 30 to 100 degrees c., and in presence of 5% platinum on carbon
11/20/2001	US6319944 Nmda nr2b antagonists; neurological and neurodegenerative diseases including pain, (and in particular neuropathic pain), epilepsy, stroke, anxiety, cerebral ischemia, muscular spasms, alzheimer's, huntington's and parkinson's diseases
11/20/2001	US6319930 Substituted dimeric compounds
11/20/2001	US6319918 For lymphoma or solid tumors treatment
11/20/2001	US6319917 Acylaminoalkenylene-amide derivatives as NK1 and NK2 antagonists
11/19/2001	CA2308994A1 Neuroprotective compounds
11/15/2001	WO2001085706A1 Substituted phenylacetamides and their use as glucokinase activators
11/15/2001	WO2001085695A1 Tetrahydroisoquinoline analogs useful as growth hormone secretagogues
11/15/2001	WO2001085694A2 Substituted diamide derivatives useful as motilin antagonists
11/15/2001	WO2001085685A1 Heterocyclic inhibitors of glycogen synthase kinase gsk-3
11/15/2001	WO2001085677A1 Amino acid derivatives and their use as medicines
11/15/2001	WO2001085146A1 Pharmaceutical compounds for treating copd
11/15/2001	WO2001040185B1 Compounds, compositions, and methods for stimulating neuronal growth and elongation
11/15/2001	WO2001017963A3 Aminoalkoxy carbazoles and their use as 5-ht ligands
11/15/2001	US20010041732 Use
11/15/2001	US20010041726 Nitrosated and nitrosylated cyclooxygenase-2 inhibitors, compositions and methods of use
11/15/2001	US20010041718 Cis-6-(4-fluoro-phenyl)-5-(4-(2-piperidin-1-yl-ethoxy)-phenyl) -5,6,7,8-tetrahydronaphthalene-2-ol, for example, and other estrogen agonists/antagonists to treat rheumatoid arthritis, colon cancer, wounds, cataracts and skin wrinkles
11/15/2001	US20010041714 Serotonin-7 (5-HT7); treatment of central nervous system disorders such as sleep disorders, depression and schizophrenia; for example 1,3-dihydro-2-((4-(4-fluorophenyl)-4-oxobutyl))isoindole
11/15/2001	DE10022925A1 New indole-carboxamide or azepino-indole derivatives and analogs, are poly-ADP ribose polymerase inhibitors useful e.g. for treating neurodegenerative disease, ischemia, epilepsy, tumors, sepsis or diabetes mellitus
11/15/2001	CA2408486A1 Tetrahydroisoquinoline analogs useful as growth hormone secretagogues
11/15/2001	CA2408288A1 Novel substituted diamine derivatives useful as motilin antagonists
11/15/2001	CA2407830A1 Amino acid derivatives and their use as medicines
11/15/2001	CA2406512A1 Pharmaceutical compounds for treating copd
11/15/2001	CA2334827A1 Trypsin substrate and diagnostic device, and method of using same
11/14/2001	EP1153921A2 Cyclic ureas and analogues useful as retroviral protease inhibitors
11/14/2001	EP1152764A1 Compositions and methods for use in targeting vascular destruction
11/14/2001	CN1321639A Substd. heterocyclic compounds, preparing process thereof and pharmaceutical composition contg them
11/14/2001	CN1321634A Substd heterocyclic compounds preparing method thereof and pharmaceutical composition contg. them
11/14/2001	CN1074756C Distillation procss for improving yield of pure products from crude anthracene
11/13/2001	US6316639 Reacting dicarboxylic acids or anhydrides with a salt of hydroxyl-amine in solution selected from hydroxylamine sulfate, hydroxylamine nitrate, hydroxylamine acetate, hydroxylamine tetrafluoroborate, hydroxylamine phosphate
11/13/2001	US6316638 Conformationally constrained amino acid compounds having affinity for the alpha2delta subunit of a calcium channel
11/13/2001	US6316635 Used in prophylaxis and therapy of protein kinase related cellular disorders such as cancer, diabetes, autoimmune disorder, hyperproliferation disorder, inflammatory disorder, angiogenesis, restenosis, fibrosis, psoriasis, osteoarthritis
11/13/2001	US6316625 Methods of making HIV-protease inhibitors and intermediates for making HIV-protease inhibitors
11/13/2001	US6316617 For treating physiological disorders associated with an excess of neuropeptide y, such as feeding disorders and certain cardiovascular diseases, medical diagnosis
11/13/2001	US6316503 For therapy of disease states associated with cholesterol metabolism such as atherosclerosis and hypercholesterolemia
11/13/2001	US6316487 For therapy of ventricular tachyarrhythmias, especially in patients with congestive heart failure and ventricular arrhythmias and supraventricular arrhythmias, including atrial fibrillation and re-entrant tachyarrhythmias
11/13/2001	US6316486 Alkyl dihalogenated phenyl-substituted ketoenols useful as pesticides and herbicides
11/13/2001	US6316484 Pentafluorobenzenesulfonamides and analogs
11/13/2001	US6316482 Benzamide derivatives having a vasopressin antagonistic activity
11/13/2001	US6316470 Benzylpiperazinyl and piperidinyl ethanone derivatives: dopamine receptor subtype specific ligands
11/13/2001	US6316459 O-benzyloxime ethers and crop protection agents containing these compounds
11/13/2001	US6316450 Compounds
11/13/2001	US6316429 Enzyme inhibitors modulate the activity of protein kinases and therefore are expected to be useful in the prevention and treatment of protein kinase related cellular disorders such as cancer.
11/13/2001	US6316421 Pentaerythritol lipid derivatives and nuleic-acid complexes
11/08/2001	WO2001084234A1 Method for immobilizing oligonucleotides employing the cycloaddition bioconjugation method
11/08/2001	WO2001083571A2 Catalysts containing n-pyrrolyl substituted nitrogen donors
11/08/2001	WO2001083474A1 Pyrimidinyl methyl indole derivatives with antibacterial activity
11/08/2001	WO2001083473A1 Process for producing optically active sulfoxide derivative
11/08/2001	WO2001083453A1 Novel substituted tricyclic compounds
11/08/2001	WO2001083450A2 (2-oxindol-3-ylidenyl)acetic acid derivatives and their use as protein kinase inhibitors
11/08/2001	WO2001083449A2 Rigid pyrrolidone modulators of pkc
11/08/2001	WO2001083448A2 Novel prodrugs von 6-hydroxy-2,3-dihydro-1h-indoles, 5-hydroxy-1,2-dihydro-3h-pyrrolo[3,2-e]indoles and 5-hydroxy-1,2-dihydro-3h-benzo(e)indoles as well as of 6-hydroxy-1,2,3,4-tetrahydro-benzo[f]quinoline derivatives for use in selective cancer therapy
11/08/2001	WO2001083439A2 Novel $g(y) crystalline form of perindopril tert-butylamine salt, preparation method, and pharmaceutical compositions containing same.
11/08/2001	WO2001083431A1 Mmp-12 inhibitors
11/08/2001	WO2001082925A1 Melanin concentrating hormone antagonists
11/08/2001	WO2000061194A3 Short-chain peptide dye conjugates used as contrast agents for optical diagnostics
11/08/2001	DE10019755A1 New cyclic carboxylic acids are integrin antagonists, useful for treating inflammatory diseases, autoimmune and immune disorders, e.g. atherosclerosis, asthma and diabetes
11/08/2001	CA2407799A1 (2-oxindol-3-ylidenyl)acetic acid derivatives and their use as protein kinase inhibitors
11/08/2001	CA2407692A1 Catalysts containing n-pyrrolyl substituted nitrogen donors
11/08/2001	CA2405607A1 Pyrimidinyl methyl indole derivatives with antibacterial activity
11/07/2001	EP1152008A2 Fluorescent nucleotides containing a cyanine, merocyanine or styryl dye for the detection of nucleic acid
11/07/2001	EP1150976A1 3-(thio-substituted amido)-lactams useful as inhibitors of matrix metalloproteinase
11/07/2001	EP1150954A1 Anti-imflammatory indole derivatives
11/07/2001	EP1150953A1 Indole derivatives and their use as mcp-1 receptor antagonists
11/07/2001	EP1150952A1 Indole derivatives and their use as mcp-1 receptor antagonists
11/07/2001	EP1150944A1 N2-phenylamidine derivatives
11/07/2001	EP0655996B1 Substituted benzylamino nitrogen containing non-aromatic heterocycles
11/07/2001	EP0546108B1 Pro-drugs for cck antagonists
11/07/2001	CN1321147A Indolin derivs. as sun protection agents
11/07/2001	CN1321140A Transfer hydrogenation process
11/07/2001	CN1320595A Process for preparing isoindoline
11/07/2001	CN1320426A Compound for treatment of female sexual dysfuction
11/07/2001	CN1074411C Method for preparing medicinal composition in noval physical form contg. heterocyclic amide deriv.
11/06/2001	US6313349 Electroluminescent intermediate
11/06/2001	US6313313 Water soluble cationic amide or ester made from reaction with 5,6-dihydroxyindole-2-carboxylic acid
11/06/2001	US6313312 3-Azabicyclo[3.1.0]hexane derivatives useful in therapy
11/06/2001	US6313298 Spiro-indolines as Y5 receptor antagonists
11/06/2001	US6313175 For therapy of obesity; for quantitating the binding of serotonin or a serotonin ligand
11/06/2001	US6313173 Glyoxylic acid amides
11/06/2001	US6313158 Bioavailability of 3-heteroarylidenyl-2-indolinones active as protein tyrosine kinase inhibitors
11/06/2001	US6313151 As inhibitors of factor xa and are used as anticoagulants in mammals
11/06/2001	US6313146 Calcium receptor-active molecules
11/06/2001	US6313126 For threrapy of disorders associated with dysfunction in serotonergic neurotransmission, including depression and anxiety
11/06/2001	US6313122 As inhibitors of factor xa and are used as anticoagulants in mammals
11/06/2001	US6313088 Carriers used to deliver various active agents through various biological, chemical, and physical barriers

1 ... 281 282 283 284 285 286 287 288 289 290 291 292 293 294 295 296 297 298 299 300 301 ... 458